This report was sent to Briefing.com subscribers earlier today.
Research calls posted earlier this morning are available here.
Upgrades:
> Algoma Steel Group (ASTL) upgraded to Buy from Hold at Stifel
> Check Point Software (CHKP) upgraded to Neutral from Sell at Citigroup
> Gap (GPS) upgraded to Equal-Weight from Underweight at Morgan Stanley
> Grifols, S.A. (GRFS) upgraded to Buy from Hold at Jefferies
> Magellan Midstream (MMP) upgraded to Overweight from Equal Weight at Barclays; tgt $59
> Nestle (NSRGY) upgraded to Hold from Underperform at Jefferies
> Oatly Group AB (OTLY) upgraded to Buy from Neutral at Mizuho; tgt raised to $6
> Pegasystems (PEGA) upgraded to Buy from Neutral at Citigroup; tgt raised to $45
> Seagate Tech (STX) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $69
> Willis Towers Watson (WTW) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt $303
Downgrades:
> Exact Sciences (EXAS) downgraded to Mkt Perform from Outperform at Raymond James
> Extra Space Storage (EXR) downgraded to Peer Perform from Outperform at Wolfe Research
> Exxon Mobil (XOM) downgraded to Sell from Neutral at Redburn
> Idorsia Ltd (IDRSF) downgraded to Hold from Buy at Jefferies
> Monarch Casino & Resort (MCRI) downgraded to Neutral from Outperform at Macquarie; tgt lowered to $81
> Morgan Stanley (MS) downgraded to Neutral from Buy at Citigroup; tgt $100
> PayPal (PYPL) downgraded to Underperform from Neutral at SMBC Nikko; tgt lowered to $75
> PennyMac (PFSI) downgraded to Mkt Perform from Mkt Outperform at JMP Securities
> Signature Bank (SBNY) downgraded to Equal-Weight from Overweight at Stephens; tgt $145
> Skechers USA (SKX) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt $46
> Terna Rete Elettrica (TERRF) downgraded to Neutral from Buy at UBS
> UGI Corp (UGI) downgraded to Underweight from Equal Weight at Barclays; tgt raised to $39
> Veracyte (VCYT) downgraded to Mkt Perform from Outperform at Raymond James
> Williams Cos (WMB) downgraded to Equal Weight from Overweight at Barclays; tgt $37
Others:
> Adobe (ADBE) initiated with a Neutral at DA Davidson; tgt $350
> BioMarin Pharmaceutical (BMRN) initiated with a Hold at Canaccord Genuity; tgt $119
> Boyd Gaming (BYD) initiated with a Buy at ROTH Capital; tgt $70
> Check Point Software (CHKP) initiated with a Sector Outperform at Scotiabank; tgt $160
> Coherent (COHR) initiated with a Buy at Rosenblatt; tgt $55
> CrowdStrike (CRWD) initiated with an Outperform at BMO Capital Markets; tgt $120
> CubeSmart (CUBE) initiated with an Outperform at Wolfe Research; tgt $48
> Datadog (DDOG) placed on Negative Catalyst Watch at Citigroup
> Fortinet (FTNT) initiated with a Sector Outperform at Scotiabank; tgt $65
> Informatica (INFA) initiated with a Sector Perform at Scotiabank; tgt $15
> Intel (INTC) placed on Negative Catalyst Watch at Citigroup
> Kornit Digital (KRNT) initiated with an Equal-Weight at Morgan Stanley; tgt $27
> Lam Research (LRCX) resumed with a Hold at Stifel; tgt $495
> Membership Collective Group (MCG) initiated with a Buy at ROTH Capital; tgt $7
> Microchip (MCHP) placed on Positive Catalyst Watch at Citigroup
> National Storage Affiliates (NSA) initiated with a Peer Perform at Wolfe Research
> Nuvalent (NUVL) initiated with an Outperform at Wedbush; tgt $39
> ON Semiconductor (ON) placed on Positive Catalyst Watch at Citigroup
> Oracle (ORCL) initiated with a Neutral at DA Davidson; tgt $85
> Palantir Technologies (PLTR) initiated with a Neutral at Mizuho; tgt $7
> Prenetics Group Ltd. (PRE) initiated with an Overweight at Cantor Fitzgerald; tgt $7
> Qualcomm (QCOM) placed on Negative Catalyst Watch at Citigroup
> Rhythm Pharmaceuticals (RYTM) resumed with a Buy at Canaccord Genuity; tgt $52
> Salesforce (CRM) initiated with a Neutral at DA Davidson; tgt $150
> SentinelOne (S) initiated with a Sector Outperform at Scotiabank; tgt $13
> Shopify (SHOP) initiated with a Neutral at DA Davidson; tgt $34
> Splunk (SPLK) placed on Positive Catalyst Watch at Citigroup
> Ultragenyx Pharma (RARE) assumed with a Buy at Canaccord Genuity; tgt $90
> Vertex Pharma (VRTX) initiated with a Hold at Canaccord Genuity; tgt $311
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
